12:00 AM
Apr 27, 2009
 |  BC Week In Review  |  Company News  |  Deals

Immuron, Hadassah Medical Organization deal

Immuron (formerly Anadis Ltd.) will acquire Hadassah's IP covering an oral immune modulation technology. Immuron initially will use the technology with its dairy-derived antibody technology to develop medical foods...

Read the full 133 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >